Clinical Trial Update: Phase IIb Study of Umeclidinium (UMEC) Bromide Versus Placebo in Subjects With Asthma [Phase 2]

View source ↗

Summary

Phase IIb study of umeclidinium bromide versus placebo in asthma completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Umeclidinium bromide (umeclidinium bromide)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2019-06-19